Dorsomorphin

BMP 和 AMPK 通路抑制剂;抑制 ALK2、ALK3、ALK6 和 AMPK

产品号 #(选择产品)

产品号 #72102_C

BMP 和 AMPK 通路抑制剂;抑制 ALK2、ALK3、ALK6 和 AMPK

总览

Dorsomorphin 通过靶向 I 型 BMP 受体激活素受体样激酶 (ALK) 2、ALK3 和 ALK6 来抑制骨形态发生蛋白 (BMP) 通路。它也是 AMP 活化蛋白激酶 (AMPK;Ki = 109 nM) 的强效抑制剂,但对 ZAPK、SYK、PKCθ、PKA 或 JAK3 等结构相关激酶的抑制作用不显著 (Bain et al., Yu et al.)。

分化
·促进人多能干细胞向神经祖细胞分化 (Morizane et al., Zhou et al.)。
·促进小鼠和人多能干细胞向心肌细胞分化(Hao et al., Kattman et al.)。
·促进脂肪细胞分化,抑制人间充质细胞向成骨细胞分化(Kim et al.)。

细胞类型
脂肪细胞,心肌细胞,PSC衍生,间充质干/祖细胞,神经细胞,PSC衍生,多能干细胞
 
种属
人,小鼠,非人灵长类,其它细胞系,大鼠
 
应用
分化
 
研究领域
神经科学,干细胞生物学
 
CAS 编号
866405-64-3
 
化学式
C₂₄H₂₅N₅O
 
纯度
≥98%
 
通路
AMPK,BMP
 
靶点
ALK2,ALK3,ALK6,AMPK
 

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Product Name
Dorsomorphin
Catalog #
72102, 100-0246
Lot #
Lot# 1000031486 or higher for 72102 | Lot# 1000027272 or higher for 100-0246
Language
English
Product Name
Dorsomorphin
Catalog #
72102, 100-0246
Lot #
Lot# 1000031485 or lower for 72102 | Lot# 1000027271 or lower for 100-0246
Language
English
Document Type
Safety Data Sheet
Product Name
Dorsomorphin
Catalog #
72102
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
Dorsomorphin
Catalog #
100-0246
Lot #
All
Language
English

Resources and Publications

Educational Materials (4)

Publications (7)

Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase. Kim E-K et al. Journal of cellular physiology 2012 APR

Abstract

AMP-activated protein kinase (AMPK) is an energy-sensing kinase that has recently been shown to regulate the differentiation of preadipocytes and osteoblasts. However, the role of AMPK in stem cell differentiation is largely unknown. Using in vitro culture models, the present study demonstrates that AMPK is a critical regulatory factor for osteogenic differentiation. We observed that expression and phosphorylation of AMPK were increased during osteogenesis in human adipose tissue-derived mesenchymal stem cells (hAMSC). To elucidate the role of AMPK in osteogenic differentiation, we investigated the effect of AMPK inhibition or knockdown on mineralization of hAMSC. Compound C, an AMPK inhibitor, reduced mineralized matrix deposition and suppressed the expression of osteoblast-specific genes, including alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2), and osteocalcin (OCN). Knockdown of AMPK by shRNA-lentivirus infection also reduced osteogenesis. In addition, inhibition or knockdown of AMPK during osteogenesis inhibited ERK phosphorylation, which is required for osteogenesis. Interestingly, inhibition of AMPK induced adipogenic differentiation of hAMSC, even in osteogenic induction medium (OIM). These results provide a potential mechanism involving AMPK activation in osteogenic differentiation of hAMSC and suggest that commitment of hAMSC to osteogenic or adipogenic lineage is governed by activation or inhibition of AMPK, respectively.
Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. Morizane A et al. Journal of neuroscience research 2011 FEB

Abstract

The balance of bone morphogenic protein (BMP), transforming growth factor-β (TGFβ)/activin/nodal, and Wnt signals regulates the early lineage segregation of human embryonic stem cells (ESCs). Here we demonstrate that a combination of small-molecule inhibitors of BMP (Dorsomorphin) and TGFβ/activin/nodal (SB431542) signals promotes highly efficient neural induction from both human ESCs and induced pluripotent stem cells (iPSCs). The combination of small molecules had effects on both cell survival and purity of neural differentiation, under conditions of stromal (PA6) cell coculture and feeder-free floating aggregation culture, for all seven pluripotent stem cell lines that we studied, including three ESC and four iPSC lines. Small molecule compounds are stable and cost effective, so our findings provide a promising strategy for controlled production of neurons in regenerative medicine.
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Kattman SJ et al. Cell stem cell 2011 FEB

Abstract

Efficient differentiation of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to a variety of lineages requires step-wise approaches replicating the key commitment stages found during embryonic development. Here we show that expression of PdgfR-α segregates mouse ESC-derived Flk-1 mesoderm into Flk-1(+)PdgfR-α(+) cardiac and Flk-1(+)PdgfR-α(-) hematopoietic subpopulations. By monitoring Flk-1 and PdgfR-α expression, we found that specification of cardiac mesoderm and cardiomyocytes is determined by remarkably small changes in levels of Activin/Nodal and BMP signaling. Translation to human ESCs and iPSCs revealed that the emergence of cardiac mesoderm could also be monitored by coexpression of KDR and PDGFR-α and that this process was similarly dependent on optimal levels of Activin/Nodal and BMP signaling. Importantly, we found that individual mouse and human pluripotent stem cell lines require optimization of these signaling pathways for efficient cardiac differentiation, illustrating a principle that may well apply in other contexts.

更多信息

更多信息
Species Human, Mouse, Non-Human Primate, Other, Rat
Cas Number 866405-64-3
Chemical Formula C₂₄H₂₅N₅O
Purity ≥ 98%
Target ALK2, ALK3, ALK6, AMPK
Pathway AMPK, BMP
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。